⚖️Proposed Schedule I Classification for 3-Methoxyphencyclidine
Schedules of Controlled Substances: Placement of 3-Methoxyphencyclidine (1-[1-(3-methoxyphenyl)cyclohexyl]piperidine) in Schedule I
Summary
The Drug Enforcement Administration proposes placing 3- methoxyphencyclidine, including its salts, isomers, and salts of isomers, an arylcyclohexylamine hallucinogen, in schedule I of the Controlled Substances Act. This action is proposed to enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substances. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess), or propose to handle 3-methoxyphencyclidine.
Agencies
- Justice Department
- Drug Enforcement Administration
Business Impact
$$$ - High
This proposed rule regarding the scheduling of 3-MeO-PCP creates significant compliance requirements for businesses that manufacture, distribute, or research this substance. They would face administrative, civil, and criminal penalties for non-compliance. The regulation imposes new registration, security, and record-keeping standards that directly affect operational processes.